Maxime Borgeaud
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 5
- Lung Cancer Research Studies 3
- Peptidase Inhibition and Analysis 2
- HER2/EGFR in Cancer Research 1
-
- Lung Cancer Treatments and Mutations 6
- Sarcoma Diagnosis and Treatment 1
- Co-authors
- Alfredo Addeo (10 shared papers)Alex Friedlaender (4 shared papers)Giuseppe Luigi Banna (3 shared papers)Olivier Michielin (1 shared paper)José Luís Sandoval (2 shared papers)Michel Obéid (1 shared paper)Xiuning Le (2 shared papers)Timothée Olivier (2 shared papers)
- Journals
- Journal of Thoracic Oncology (2 papers)BioDrugs (1 paper)JCI Insight (1 paper)CA A Cancer Journal for Clinicians (1 paper)Cancer Treatment Reviews (1 paper)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Maxime Borgeaud
12 papers receiving 317 citations
Maxime Borgeaud's Hit Papers
Peers
Comparison fields: 5 of 45
- Oncology 151
- Pulmonary and Respiratory Medicine 137
- Cancer Research 42
- Immunology 43
- Molecular Biology 80
Countries citing papers authored by Maxime Borgeaud
This map shows the geographic impact of Maxime Borgeaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Borgeaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Borgeaud more than expected).
Fields of papers citing papers by Maxime Borgeaud
This network shows the impact of papers produced by Maxime Borgeaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Borgeaud. The network helps show where Maxime Borgeaud may publish in the future.
Co-authors
The 25 scholars most cited alongside Maxime Borgeaud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Oncogenic driver mutations in non-small cell lung cancer: Past, present and future Hit paper breakdown → | 2021 | 171 |
| 2 | 2023 | 84 | |
| 3 | 2024 | 29 | |
| 4 | 2025 | 11 | |
| 5 | 2023 | 6 | |
| 6 | 2024 | 6 | |
| 7 | 2025 | 5 | |
| 8 | 2025 | 4 | |
| 9 | 2024 | 4 | |
| 10 | 2025 | 1 | |
| 11 | 2025 | 1 | |
| 12 | 2023 | 1 | |
| 13 | 2021 | 0 | |
| 14 | 2024 | 0 |
About Maxime Borgeaud
Maxime Borgeaud is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Pathology and Forensic Medicine, having authored 14 papers that have together received 323 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Research Studies (3 papers), Peptidase Inhibition and Analysis (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Immune Cell Function and Interaction (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Oncology (151 citations), Pulmonary and Respiratory Medicine (137 citations), Cancer Research (42 citations), Immunology (43 citations) and Molecular Biology (80 citations). Maxime Borgeaud has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Alfredo Addeo, Alex Friedlaender, Giuseppe Luigi Banna, Olivier Michielin, José Luís Sandoval, Michel Obéid, Xiuning Le, Timothée Olivier, Kaushal Parikh and Annapaola Mariniello. Their work appears in journals such as Journal of Thoracic Oncology, BioDrugs, JCI Insight, CA A Cancer Journal for Clinicians and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.